• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA VASCULAR; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26924
Medical Device Problem Codes Premature Activation (1484); Failure to Advance (2524)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/02/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the stent inadvertently deployed.A 7 x 40 x 130 innova self-expanding stent was selected for use in a vascular intervention.A contralateral approach was used to access the 99% stenosed target lesion that was severely calcified and located in the moderately tortuous superficial femoral artery.The lesion was pre-dilated with a balloon, but the innova would not cross the lesion.The device was removed.The stent looked defective; it looked like the middle catheter had come back, so the distal tip of the stent was exposed.Another innova stent was used to complete the procedure.No patient complications were reported.
 
Event or Problem Description
It was reported that the stent inadvertently deployed.A 7 x 40 x 130 innova self-expanding stent was selected for use in a vascular intervention.A contralateral approach was used to access the 99% stenosed target lesion that was severely calcified and located in the moderately tortuous superficial femoral artery.The lesion was pre-dilated with a balloon, but the innova would not cross the lesion.The device was removed.The stent looked defective; it looked like the middle catheter had come back, so the distal tip of the stent was exposed.Another innova stent was used to complete the procedure.No patient complications were reported.
 
Additional Manufacturer Narrative
Device eval by manufacturer: returned product consisted of an innova self-expanding stent system.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone.The stent was partially deployed 1.3cm from the middle sheath.Microscopic examination revealed no additional damages.The pull rack and yellow thumbwheel lock were still in the manufactured position.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA VASCULAR
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16048585
Report Number2124215-2022-54561
Device Sequence Number20442312
Product Code NIP
UDI-Device Identifier08714729874089
UDI-Public08714729874089
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P140028
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number26924
Device Catalogue Number26924
Device Lot Number0028918802
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/02/2022
Supplement Date Received by Manufacturer01/25/2023
Initial Report FDA Received Date12/26/2022
Supplement Report FDA Received Date02/15/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/22/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-